Dogwood TherapeuticsDWTX
13F holders, Q4 2025 (December 31)10holders −2
2new positions
4sold out
$4.16avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Dogwood Therapeutics Inc. (DWTX) in their 13F filings, down 2 from Q3 2025. 2 opened new positions and 4 sold out. The largest holders were Vanguard Group Inc. ($125K), Geode Capital Management, LLC ($70K) and Marshall Wace, LLP ($48K).
- Company
- Dogwood Therapeutics Inc.
- CUSIP
- 92829J203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $56K |
| Exits | 4 | $7K |
All 13F filers, Q3 2025 → Q4 2025: 32,273 shares bought and 980 shares sold, net +31,293 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Vanguard Group Inc. | 0.00% | Add +35.1% | 29,955 | $125K |
| Geode Capital Management, LLC | 0.00% | Add +11.2% | 16,779 | $70K |
| Marshall Wace, LLP | 0.00% | New | 11,655 | $48K |
| Bank of America Corp. | 0.00% | Add +58743.8% | 9,415 | $39K |
| UBS Group AG | 0.00% | New | 1,748 | $7K |
| Morgan Stanley | 0.00% | Reduce -20.5% | 477 | $2K |
| Activest Wealth Management | 0.00% | No change | 120 | $499 |
| BlackRock, Inc. | 0.00% | No change | 30 | $125 |
| Group One Trading LLC | 0.00% | No change | 9 | $37 |
| BNP Paribas Financial Markets | 0.00% | Reduce -80.0% | 2 | $8 |
"% of holder's portfolio" is DWTX's weight in each manager's 13F, not the share of Dogwood Therapeutics Inc. the manager owns.